PLRX 241220 7.50C (PLRX241220C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PLRX241220C7500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 22 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Leerink Partners Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $33
Moomoo NewsNov 19 03:36 ET · Ratings
Positive Developments in Pliant Therapeutics' IPF Research Bolster Buy Rating
TipRanksNov 19 01:56 ET · Ratings
Pliant Therapeutics Reports Increased Losses and Strategic Focus
TipRanksNov 18 22:55 ET
Express News | Pliant Therapeutics Plans To Present Data From Bexotegrast Program At Liver Meeting 2024
BenzingaNov 18 18:01 ET
Pliant Therapeutics Presents Data From Its Bexotegrast Program at The Liver Meeting 2024
GlobeNewswireNov 18 18:00 ET
Pliant Therapeutics Insiders Sold US$574k Of Shares Suggesting Hesitancy
Simply Wall StNov 17 07:07 ET

Comments

Stock_Drift

Nov 18 18:13

$Pliant Therapeutics (PLRX.US)$

Moomoo AI

Nov 20, 2023 09:05

Despite a robust balance sheet and good liquidity, Pliant Therapeutics faced a 64% revenue shrink to US$3.5m last year, questioning its future profitability. After burning through US$124m cash and a US$155m loss, it might need to raise capital soon.

Is Pliant Therapeutics (NASDAQ:PLRX) Using Debt Sensibly?

GAME_DAY

Jan 23, 2023 07:47

TOP AM WATCH ⚡️

GNS INBS VERB ALLR COSM HLBZ JFBR PLRX KR NKE
$Genius Group (GNS.US)$ $Intelligent Bio Solutions (INBS.US)$ $Verb Technology (VERB.US)$ $Allarity Therapeutics (ALLR.US)$ $Cosmos Health (COSM.US)$ $Helbiz (HLBZ.US)$ $Jeffs' Brands (JFBR.US)$ $Pliant Therapeutics (PLRX.US)$ $The Kroger (KR.US)$ $Nike (NKE.US)$

Be a voice no echo

Jan 23, 2023 07:45

buying

$Pliant Therapeutics (PLRX.US)$

ilovemoney29

Jan 23, 2023 05:49

if $Novocure (NVCR.US)$ is an example of a pharma company that met endpt for its lung trials, then $Pliant Therapeutics (PLRX.US)$ should follow suit.
might see 55 or above 60 for PLRX today